Enzon Pharmaceuticals, Inc. (BST:EZ1)

Germany flag Germany · Delayed Price · Currency is EUR
0.0485
0.00 (0.00%)
At close: Feb 27, 2026
-31.69%
Market Cap 3.77M
Revenue (ttm) n/a
Net Income (ttm) -3.14M
Shares Out n/a
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume 627
Open 0.0485
Previous Close 0.0485
Day's Range 0.0485 - 0.0485
52-Week Range 0.0200 - 0.1200
Beta n/a
RSI 49.23
Earnings Date Feb 20, 2026

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 1981
Employees 1
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol EZ1
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.